Pharmacia Plans Camptosar Submission For Labeling Change By Year-End
Executive Summary
Pharmacia will submit a labeling change proposal for its colorectal cancer therapy Camptosar by the end of the year based on FDA's Oncologic Drugs Advisory Committee Dec. 6 review of postmarketing safety